Literature DB >> 14744086

Identification of parasite antigen, correlation of parasite density and inflammation in skin lesions of post kala-azar dermal leishmaniasis.

K R Beena1, V Ramesh, Ashok Mukherjee.   

Abstract

BACKGROUND: Post kala-azar dermal leishmaniasis (PKDL) is an unusual dermatosis following kala-azar (KA). Demonstration of the amastigotes in lesions plays an important role in the diagnosis of PKDL. It was aimed to evaluate the utility of an antibody G2D10 in detecting leishmania parasite antigen, to correlate the parasite number/percentage of parasites with the inflammation, and to assess the epidemiological significance associated with the location of the parasites.
MATERIAL AND METHODS: The study was conducted on 50 cases. Hematoxylin and eosin (H & E) stains and immunohistochemical (IHC) stains, using G2D10 antibody, was performed on the skin biopsies. The number of parasites and density of inflammation were semiquantitatively assessed.
RESULTS: Leishmania donovan bodies (LDBs) were identified in 50% of cases with the H & E compared to 80% positivity with the IHC. All 50 cases showed inflammation in the superficial dermis (SD). About 44% showed dense inflammation compared to 16% sparse and 40% moderate inflammation. Parasite percentage was maximum in the SD (100%) compared to 75 and 42% in the mid and deep dermis, respectively.
CONCLUSIONS: The IHC showed a higher percentage of LDB localization (80 vs. 50%). Density of inflammation was maximum in the SD. The parasite percentage was correlated with the inflammation. Location of parasites could have an epidemiological significance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14744086     DOI: 10.1034/j.1600-0560.2003.00125.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  8 in total

Review 1.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

2.  Imaging Leishmania major Antigens in Experimentally Infected Macrophages and Dermal Scrapings from Cutaneous Leishmaniasis Lesions in Tunisia.

Authors:  Nasreddine Saïdi; Yousr Galaï; Meriem Ben-Abid; Thouraya Boussoffara; Ines Ben-Sghaier; Karim Aoun; Aïda Bouratbine
Journal:  Microorganisms       Date:  2022-06-04

Review 3.  Exclusive Primary Lesion of Oral Leishmaniasis with Immunohistochemical Diagnosis.

Authors:  Tatiana Fernandes Araujo Almeida; Esmeralda Maria da Silveira; Cássio Roberto Rocha Dos Santos; Jorge Esquiche León; Ana Terezinha Marques Mesquita
Journal:  Head Neck Pathol       Date:  2016-06-03

4.  Diagnostic usefulness of immunohistochemical evaluation of CD1a antigen and polyclonal anti-leishmania antibodies in cutaneous leishmaniasis.

Authors:  Emilio Lopez-Trujillo; Mònica Gonzàlez-Farré; Ramon M Pujol; Beatriz Bellosillo; Roser Fisa; Cristina Riera; Magdalena Alcover; Carlos Barranco; Gemma Martin-Ezquerra
Journal:  Histol Histopathol       Date:  2021-03-04       Impact factor: 2.303

5.  Histopathology of Post Kala-azar Dermal Leishmaniasis.

Authors:  V Ramesh; M Ramam
Journal:  Indian J Dermatol       Date:  2020 Nov-Dec       Impact factor: 1.494

6.  Anti-mitochondrial Tryparedoxin Peroxidase Monoclonal Antibody-Based Immunohistochemistry for Diagnosis of Cutaneous Leishmaniasis.

Authors:  Mariana Lourenço Freire; Felipe Dutra Rego; Karine Ferreira Lopes; Lucélia Antunes Coutinho; Rafaella Fortini Queiroz Grenfell; Daniel Moreira Avelar; Gláucia Cota; Marcelo Antônio Pascoal-Xavier; Edward Oliveira
Journal:  Front Microbiol       Date:  2022-02-28       Impact factor: 5.640

7.  Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL).

Authors:  Emily R Adams; Inge Versteeg; Mariska M G Leeflang
Journal:  J Trop Med       Date:  2013-07-09

Review 8.  Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.

Authors:  Maria Angela Bianconcini Trindade; Lana Luiza da Cruz Silva; Lucia Maria Almeida Braz; Valdir Sabbaga Amato; Bernard Naafs; Mirian Nacagami Sotto
Journal:  BMC Infect Dis       Date:  2015-11-23       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.